Skip to main content

Guidance and regulation

Skip to results
13 results sorted by Most viewed
From Life Sciences Organisation (LSO)
  • Guide for overseas investors on how to access NHS procurement channels.

  • Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

  • Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.

  • Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

  • Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

  • Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.

  • Overview of the UK's orthopaedics research infrastructure and advantages of investment in the UK's life science sector to support new treatments and technology.

  • Overview of organisations supporting life sciences in the UK, organised by sub-sector and stage of product or service development.

  • Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.

  • Overview of the UK's infectious diseases diagnostics (IDD) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

  • Overview of UK research infrastructure to develop new medical technology and advantages of investment in the UK's life science sector to support new products.

  • Overview of the UK's medical imaging infrastructure and advantages of investment in the UK's life science sector to develop new technology.

  • Overview of the UK's advanced wound-care research infrastructure and advantages of investment in the UK's life science sector to support new treatments.